A hemifacial transplantation model in rabbits

Annals of Plastic Surgery

Volumn 56, Issue 6, 2006, Pages 665-669

  Xudong, Zhang ^a   Shuzhong, Guo ^a   Yan, Han ^a   Datai, Wang ^a   Yunzhi, Ni ^a   Linxi, Zhang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Allotransplantation; Face; Rabbits

Indexed keywords

ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; GRAFT SURVIVAL; HEMIFACIAL TRANSPLANTATION; HISTOPATHOLOGY; NONHUMAN; POSTOPERATIVE COMPLICATION; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; RABBIT; SURGICAL APPROACH; SURGICAL TECHNIQUE; TISSUE TRANSPLANTATION; TRANSPLANTATION;

ANIMALS; DISSECTION; EAR, EXTERNAL; FACE; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MODELS, ANIMAL; RABBITS; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 33744783113     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sap.0000202829.24619.19     Document Type: Article

References (23)

1. Petit F, Paraskevas A, Minns AB, et al. Face transplantation: where do we stand? Plast Reconstr Surg. 2004;113:1429-1433.
2. Hettiaratchy S, Butler PE. Face transplantation: fantasy or the future? Lancet. 2002;360:5-6.
3. Hettiaratchy S, Butler PE. Extending the boundaries of transplantation. BMJ. 2003;326:1226-1227.
4. Jones JW Jr, Ustuner ET, Zdichavsky M, et al. Long-term survival of an extremity composite tissue allograft with FK506-mycophenolate mofetil therapy. Surgery. 1999;126:384-388.
5. Siemionow M, Ozmen S, Demir Y. Prospects for facial allograft transplantation in humans. Plast Reconstr Surg. 2004;113:1421-1428.
6. Siemionow M, Agaoglu G. Allotransplantation of the face: how close are we? Clin Plast Surg. 2005;32:401-409.
7. Dubernard JM. Composite tissue allografts: a challenge for transplantologists. Am J Transplant. 2005;5:1580-1581.
8. Ulusal BG, Ulusal AE, Ozmen S, et al. A new composite facial and scalp transplantation model in rats. Plast Reconstr Surg. 2003;112:1302-1311.
9. Demir Y, Ozmen S, Klilczak A, et al. Tolerance induction in composite facial allograft transplantation in the rat model. Plast Reconstr Surg. 2004;114:1790-1801.
10. Eduardo Bermu Dez L, Santamaria A, Romero T, et al. Experimental model of facial transplant. Plast Reconstr Surg. 2002;110:1374-1375.
11. Cantarovich D, Karam G, Giral-Classe M, et al. Randomized comparison of triple therapy and antithymocyte globulin induction treatment after simultaneous pancreas-kidney transplantation. Kidney Int. 1998;54:1351-1356.
12. Hall BM, Tiller DJ, Hardie I, et al. Comparison of three immunosuppressive regimens in cadaver renal transplantation: long-term cyclosporine, short-term cyclosporine followed by azathioprine and prednisolone, and azathioprine and prednisolone without cyclosporine. N Engl J Med. 1988;318:1499-1507.
13. Ketel BL, Turton-Weeks S, Reed K, et al. Tacrolimus-based vs cyclosporine-based immunotherapy in combined kidney-pancreas transplantation. Transplant Proc. 1996;28:899.
14. Ponticelli C, Tarantino A, Segoloni GP, et al. A randomized study comparing three cyclosporine-based regimens in cadaveric renal transplantation: Italian Multicentre Study Group for Renal Transplantation (SIMTRe). J Am Soc Nephrol. 1997;8:638-646.
15. Schnitzler MA, Craig KE, Hardinger KE, et al. Mycophenolate mofetil is associated with less death with function than azathioprine in cadaveric renal transplantation. Nephrol Dial Transplant. 2003;18:1197-1200.
16. Keven K, Sahin M, Kutlay S, et al. Immunoglobulin deficiency in kidney allograft recipients: comparative effects of mycophenolate mofetil and azathioprine. Transpl Infect Dis. 2003;5:181-186.
17. Kelly D, Jara P, Rodeck B, et al. Tacrolimus and steroids versus cyclosporin microemulsion, steroids, and azathioprine in children undergoing liver transplantation: randomised European multicentre trial. Lancet. 2004;364:1054-1061.
18. Lu JS, Xiao XR, Ao JH, et al. Necessity and safety of conversion from mycophenolate mofetil to azathioprine after renal transplantation. Zhonghua Yi Xue Za Zhi. 2005;85:657-660.
19. Pascual J, Marcen R, Orofino L, et al. Evidence that addition of azathioprine improves renal function in cyclosporine-treated patients with allograft dysfunction. Transplantation. 1991;52:276-279.
20. Smith KA. Interleukin-2: inception, impact and implications. Science. 1988;240:1169-1176.
21. Bishop GA, Wang C, Sharland AF, et al. Spontaneous acceptance of liver transplants in rodents: evidence that liver leucocytes induce recipient T-cell death by neglect. Immunol Cell Biol. 2002;80:93-100.
22. Sharland AF, Shastry S, Wang C, et al. Kinetics of intragraft cytokine expression, cellular infiltration and cell death in rejection of renal allografts compared with acceptance of liver allografts in a rat model: early activation and apoptosis is associated with liver graft acceptance. Transplantation. 1998;65:1370-1377.
23. Qian S, Lu L, Fu F, et al. Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol. 1997;158:4654-4661.